Tamboli Irfan Y, Heo Dongeun, Rebeck G William
Department of Neuroscience, Georgetown University, Washington DC., United States of America.
PLoS One. 2014 Mar 27;9(3):e93120. doi: 10.1371/journal.pone.0093120. eCollection 2014.
Under normal conditions, brain apolipoprotein E (apoE) is secreted and lipidated by astrocytes, then taken up by neurons via receptor mediated endocytosis. Free apoE is either degraded in intraneuronal lysosomal compartments or released. Here we identified a novel way by which apoE undergoes proteolysis in the extracellular space via a secreted neuronal protease. We show that apoE is cleaved in neuronal conditioned media by a secreted serine protease. This apoE cleavage was inhibited by PMSF and α1-antichymotrypsin, but not neuroserpin-1 or inhibitors of thrombin and cathepsin G, supporting its identity as a chymotrypsin like protease. In addition, apoE incubation with purified chymotrypsin produced a similar pattern of apoE fragments. Analysis of apoE fragments by mass spectrometry showed cleavages occurring at the C-terminal side of apoE tryptophan residues, further supporting our identification of cleavage by chymotrypsin like protease. Hippocampal neurons were more efficient in mediating this apoE cleavage than cortical neurons. Proteolysis of apoE4 generated higher levels of low molecular weight fragments compared to apoE3. Primary glial cultures released an inhibitor of this proteolytic activity. Together, these studies reveal novel mechanism by which apoE can be regulated and therefore could be useful in designing apoE directed AD therapeutic approaches.
在正常情况下,脑载脂蛋白E(apoE)由星形胶质细胞分泌并脂化,然后通过受体介导的内吞作用被神经元摄取。游离的apoE要么在神经元内溶酶体区室中降解,要么被释放。在这里,我们发现了一种新的方式,即apoE通过一种分泌型神经元蛋白酶在细胞外空间进行蛋白水解。我们表明,apoE在神经元条件培养基中被一种分泌型丝氨酸蛋白酶切割。这种apoE切割被苯甲基磺酰氟(PMSF)和α1-抗糜蛋白酶抑制,但不被神经丝氨酸蛋白酶-1或凝血酶和组织蛋白酶G的抑制剂抑制,这支持了它作为一种类糜蛋白酶的身份。此外,将apoE与纯化的糜蛋白酶一起孵育会产生类似的apoE片段模式。通过质谱分析apoE片段表明,切割发生在apoE色氨酸残基的C末端一侧,进一步支持了我们对类糜蛋白酶切割的鉴定。海马神经元比皮质神经元更有效地介导这种apoE切割。与apoE3相比,apoE4的蛋白水解产生了更高水平的低分子量片段。原代胶质细胞培养物释放出这种蛋白水解活性的抑制剂。总之,这些研究揭示了apoE可以被调节的新机制,因此可能有助于设计针对apoE的阿尔茨海默病治疗方法。